Greg Dietsch's Colleagues at SGB Inc
Greg Dietsch's Contact Details
HQ
760-718-3120
760-718-3120
Location
Snohomish, Washington, United States
Snohomish, Washington, United States
Company
SGB Inc
SGB Inc
Greg Dietsch's Company Details
VentiRx is a clinical stage biopharmaceutical company committed to the development and commercialization of novel Toll-like Receptor 8 (TLR8) immunotherapies for the treatment of cancer, respiratory and inflammatory diseases. VentiRx has a broad clinical pipeline. The lead clinical oncology asset, VTX-2337, is a small molecule TLR8 agonist, currently in multiple clinical trials in combination with chemotherapies and monoclonal antibodies. The company has entered into a worldwide strategic collaboration with Celgene Corporation for this program.
Frequently Asked Questions about Greg Dietsch
Greg Dietsch currently works for SGB Inc.
Greg Dietsch's role at SGB Inc is VP or Research.
Greg Dietsch's email address is ***@sgbiofuels.com. To view Greg Dietsch's full email address, please signup to ConnectPlex.
Greg Dietsch works in the BioTech/Drugs industry.
Greg Dietsch's phone number is 760-718-3120